Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting
RJ Gralla, LM Itri, SE Pisko, AE Squillante, DP Kelsen, DW Braun, LA Bordin, TJ Braun, and CW Young
In a study of the effectiveness of high intravenous doses of metoclopramide as an antiemetic, 41 patients with advanced cancer who were being treated with cisplatin were entered into two double-blind trials. In the first trial patients were randomly assigned to receive either metoclopramide or placebo, and in the second trial they received either metoclopramide or prochlorperazine. Patients given metoclopramide had significantly fewer episodes of emesis than patients given placebo (medians, 1.0 vs. 10.5; P = 0.001) or prochlorperazine (medians, 1.5 vs. 12.0; P = 0.005). Metoclopramide was superior to placebo and to prochlorperazine in reducing the volume of emesis (P = 0.001 and P = 0.022, respectively) and was more effective than placebo in shortening the duration of nausea (P = 0.042) and vomiting (P = 0.028). Side effects from metoclopramide were minor, with mild sedation frequently observed; one patient had a brief extrapyramidal reaction. We conclude that metoclopramide in high intravenous doses has greater antiemetic activity than placebo or prochlorperazine in patients receiving cisplatin chemotherapy.
This article has been cited by other articles:
Kloth, D. D.
(2009). New pharmacologic findings for the treatment of PONV and PDNV. Am J Health Syst Pharm
66: S11-S18
[Abstract][Full Text]
Daugherty, C. K., Ratain, M. J., Emanuel, E. J., Farrell, A. T., Schilsky, R. L.
(2008). Ethical, Scientific, and Regulatory Perspectives Regarding the Use of Placebos in Cancer Clinical Trials. JCO
26: 1371-1378
[Abstract][Full Text]
Wood, G. J., Shega, J. W., Lynch, B., Von Roenn, J. H.
(2007). Management of Intractable Nausea and Vomiting in Patients at the End of Life: "I Was Feeling Nauseous All of the Time . . . Nothing Was Working". JAMA
298: 1196-1207
[Abstract][Full Text]
Hartvig, P.
(2007). Letter to the editor. J Oncol Pharm Pract
13: 57-58
Kris, M. G., Hesketh, P. J., Somerfield, M. R., Feyer, P., Clark-Snow, R., Koeller, J. M., Morrow, G. R., Chinnery, L. W., Chesney, M. J., Gralla, R. J., Grunberg, S. M.
(2006). American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006. JCO
24: 2932-2947
[Abstract][Full Text]
Emanuel, E. J., Miller, F. G.
(2001). The Ethics of Placebo-Controlled Trials -- A Middle Ground. NEJM
345: 915-919
[Full Text]
Campos, D., Pereira, J. R., Reinhardt, R. R., Carracedo, C., Poli, S., Vogel, C., Martinez-Cedillo, J., Erazo, A., Wittreich, J., Eriksson, L.-O., Carides, A. D., Gertz, B. J.
(2001). Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone Alone. JCO
19: 1759-1767
[Abstract][Full Text]
Gralla, R. J., Osoba, D., Kris, M. G., Kirkbride, P., Hesketh, P. J., Chinnery, L. W., Clark-Snow, R., Gill, D. P., Groshen, S., Grunberg, S., Koeller, J. M., Morrow, G. R., Perez, E. A., Silber, J. H., Pfister, D. G.
(1999). Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines. JCO
17: 2971-2971
[Full Text]
Tomioka, S., Kurio, T., Takaishi, K., Nakajo, N.
(1999). Propofol Is Effective in Chemotherapy-Induced Nausea and Vomiting: A Case Report with Quantitative Analysis. Anesth. Analg.
89: 798-798
[Full Text]
Go, R. S., Adjei, A. A.
(1999). Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin. JCO
17: 409-409
[Abstract][Full Text]
Wetzel, C. H. R., Hermann, B., Behl, C., Pestel, E., Rammes, G., Zieglgänsberger, W., Holsboer, F., Rupprecht, R.
(1998). Functional Antagonism of Gonadal Steroids at the 5-Hydroxytryptamine Type 3 Receptor. Mol. Endocrinol.
12: 1441-1451
[Abstract][Full Text]
Lankiewicz, S., Lobitz, N., Wetzel, C. H. R., Rupprecht, R., Gisselmann, G., Hatt, H.
(1998). Molecular Cloning, Functional Expression, and Pharmacological Characterization of 5-Hydroxytryptamine3 Receptor cDNA and Its Splice Variants from Guinea Pig. Mol. Pharmacol.
53: 202-212
[Abstract][Full Text]
Werning, J. W., Stepnick, D. W., Jafri, A., Megerian, C. A., Antunez, A. R., Zaidi, S. I. A.
(1995). Metoclopramide Enhances the Effect of Photodynamic Therapy on Xenografted Human Squamous Cell Carcinoma of the Head and Neck. Arch Otolaryngol Head Neck Surg
121: 783-789
[Abstract]
Grunberg, S. M., Hesketh, P. J.
(1993). Control of Chemotherapy-Induced Emesis. NEJM
329: 1790-1796
[Full Text]
Durivage, H. J., Burnham, N. L.
(1991). Prevention and Management of Toxicities Associated With Antineoplastic Drugs. Journal of Pharmacy Practice
4: 27-48
Allan, S. G
(1988). Review article : Emesis in the patient with advanced cancer. Palliat Med
2: 89-100
[Abstract]
